Ajay Nooka

46PUBLICATIONS
220CO-AUTHORS
AutoimmunityGene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|May 22, 2026
Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early Intervention.

|May 20, 2026
Efficacy and safety of elranatamab in patients with relapsed or refractory multiple myeloma: A US subgroup analysis from MagnetisMM-3.

|Apr 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference.

|Mar 02, 2026
Efficacy and Safety of Belantamab Mafodotin with Bortezomib plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: The DREAMM-6 Arm B Trial.

Rakesh Popat, Bradley Augustson, Paul Cannell

|Jan 04, 2026
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort.

Thomas G Martin, María-Victoria Mateos, Jun Ho Yi

|Dec 09, 2025
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.

Denis J Ohlstrom, William C Pilcher, Marina E Michaud

Pageof 8

Frequent Collaborators

12 joint publications

Jonathan L Kaufman

11 joint publications

Sagar Lonial

11 joint publications

Madhav V Dhodapkar

8 joint publications

Nisha S Joseph